EULAV Asset Management

Q2 2021 13F-HR Holdings

Location
New York, NY
Holdings as of
6/30/2021
Date filed
8/6/2021
Form type
13F-HR
Num holdings
222
Total value ($000)
$3,783,090
Net value change ($000)
+50,934 (1.4%)
New positions
2
Sold out positions
17
Turnover %
2.7%
Sector allocation + QoQ delta (equities-only)
Prev filing: 4/30/2021 Next filing: 11/15/2021 SEC filing

Snapshot: Change Analysis

Compared to Q1 2021
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
IDXX 13,400 29.1%
DHR 13,098 19.2%
BIIB 12,812 NEW
CRM 12,738 21.5%
INTU 12,661 28.0%
POOL 12,374 32.9%
Biohaven Pharmaceutical Holding Co Ltd. 11,853 50.3%
ROP 11,211 16.6%
ADBE 11,205 22.0%
PTON 8,169 42.7%
Top Reduces (Value $000, Stocks/ETFs)
AKX -21,295 -29.2%
EXEL -18,584 -33.4%
JKHY -12,201 -42.4%
RNG -11,736 -38.3%
ADP -11,289 -100.0%
BALL -11,264 -41.7%
EW -10,288 -100.0%
HEI -9,527 -20.5%
EPAM -9,023 -37.8%
BMY -8,528 -100.0%
Instrument mix + QoQ Δ (ex-options)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type